60.87 USD
↘ 0.15 (0.24%)AT CLOSE (11:59 AM EDT)
Enliven Therapeutics, Inc. Common Stock
ELVNNASDAQ • USD
60.78
↘ 0.09 (0.14%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
60.78
↘ 0.09 (0.14%)
Market: CLOSED
ELVN is currently priced at $60.87. The technical outlook is "Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, ELVN trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 26, 2026.
Open?$61.03
High?$61.80
Low?$59.79
Prev. Close?$61.01
Volume?1.0M
Avg. Volume?956.3K
VWAP?$61.02
Rel. Volume?1.05x
Bid / Ask
Bid?$60.25 × 200
Ask?$61.00 × 100
Spread?$0.75
Midpoint?$60.63
Valuation & Ratios
Market Cap?4.5B
Shares Out?73.3M
Float?60.8M
Float %?83.0%
P/E Ratio?N/A
P/B Ratio?4.98
EPS?-$1.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Employees
67
Market Cap
4.5B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-02-24
Address
205 PARK ROAD
BURLINGAME, CA 94010
Phone: 650-547-5814
BURLINGAME, CA 94010
Phone: 650-547-5814
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?34
Piotroski F-Score?0/9Weak
Altman Z-Score?177.63Safe
Confidence?52%Low
Short InterestHigh
Short % of Float?13.58%High
Short Interest?8.3M
Days to Cover?6.3
Free Float60.8M
Avg Daily Volume1.3M
Settlement Date2026-08-14
Financial Health
Current Ratio?64.07Strong
Quick Ratio?64.07Strong
Cash Ratio?9.57Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score83/100
P/E?N/A▾
P/B?4.98FAIR▾
Peers100
S&P37
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-34.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-11.8%WEAK▾
S&P9
ROA?-11.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-67037000
Enterprise Value?$4.3B
Fundamentals ratios updated end of day